Spectur’s September quarter revenue already surpassed previous results

Spectur’s September quarter revenue already surpassed previous results

Perth based technology solution company Spectur Limited (ASX:SP3) today declared the revenue of its first two months for September quarter 2018. Company’s revenue for July and August has sky-rocketed to $800,000, posting more than 2-fold increase compared to previous corresponding period revenue of $275,000.

The finishing line of September quarter is around the corner but before reaching to the end, revenue for September quarter has left behind the June’18 quarter revenue of $755,000.

But that’s not an end as the company forecast revenue for September quarter’18 to shoot as high as $1,000,000, marking another record high for the company.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

Security surveillance camera company, Spectur has accredited this massive growth to east coast expansion which continue to boost the business activities. The company also eyes the recent improvement in pricing of products and services which has enabled them to align their overall gross margin with the previously announced strategy.

In response to the strong demand for Spectur’s camera, the company has invested in additional stock in the first two months of the current quarter, i.e. September 2018 quarter.

Spectur MD, Peter Holton stated: “We also have turned our attention to a refined pricing strategy to further improve gross margins. We are actively targeting larger company wide contracts to Tier 1 clients for enterprise level solutions as well as continuing to explore new business activities in new industries and verticals outside of traditional security.”

Furthermore, with the view to support the east coast operations, the company looks forward to reallocating some of its operational and capital expenditure.

Spectur Limited’s stock is trading at $0.260, recording no daily price change on 6 September 2018 (3:31 PM AEST) .

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report